Duodenal switch versus gastric bypass in patients with a body mass index (BMI) greater than 48 kg/m^2

Duodenal switch versus gastric bypass in patients with a body mass index (BMI) greater than 48 kg/m^2: a prospective randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN10940791

Enrollment

Registered

2010-11-24

Start date

2004-01-01

Completion date

Unknown

Last updated

2023-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity Nutritional, Metabolic, Endocrine Obesity

Interventions

Biliopancreatic diversion with duodenal switch (DS) versus Roux-en-Y Gastic bypass (RYGBP). The aim is to compare perioperative safety as well as long term effects on weight, comorbidities and gastroi

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients (aged over 18 years, either sex) with BMI greater than 48 kg/m^2 referred for bariatric surgery

Exclusion criteria

Exclusion criteria: 1. Language difficulties 2. Previous problems of diarrhoea 3. Suspected inflammatory bowel disease

Design outcomes

Primary

Measure	Time frame
1. Weight result, measured at 3 years 2. Peri-operative safety, collected at the time of surgery	—

Secondary

Measure	Time frame
1. Gastrointestinal symptoms, measured at 3 years 2. Long-term surgical complications, measured at 3 years 3. Metabolical evaluation, measured at 3 years 4. Overall satisfaction, measured at 3 years	—

Countries

Sweden

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 27, 2026